热门资讯> 正文
2025-11-13 05:31
DiaMedica Therapeutics (NASDAQ: DMAC) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. This is a 13.33 percent decrease over losses of $(0.15) per share from the same period last year.